Man Group PLC Spectrum Pharmaceuticals Inc Transaction History

Man Group PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.43 - $1.56 $8,433 - $30,594	19,612 Added 134.37%	34,208 $15,000
Q2 2022 Aug 15, 2022	BUY	$0.7 - $1.4 $10,217 - $20,434	14,596 New	14,596 $11,000
Q2 2020 Aug 14, 2020	SELL	$2.11 - $3.38 $55,222 - $88,461	-26,172 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$1.83 - $3.45 $47,894 - $90,293	26,172 New	26,172 $61,000
Q1 2019 May 15, 2019	SELL	$9.08 - $11.84 $120,764 - $157,472	-13,300 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$6.39 - $16.99 $1.11 Million - $2.96 Million	-174,371 Reduced 92.91%	13,300 $116,000
Q3 2018 Nov 14, 2018	BUY	$16.52 - $24.82 $3.1 Million - $4.66 Million	187,671 New	187,671 $3.15 Million
Q2 2018 Aug 14, 2018	SELL	$14.31 - $21.75 $1.39 Million - $2.11 Million	-97,068 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$16.09 - $23.07 $1.56 Million - $2.24 Million	97,068 New	97,068 $1.56 Million

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.